🇺🇸 FDA
Patent

US 6051232

Chimeric MHC class I antigens for inducing allograft tolerance

expired A61KA61K38/00A61K38/13

Quick answer

US patent 6051232 (Chimeric MHC class I antigens for inducing allograft tolerance) held by The Board of Regents of the University of Texas System expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/13, A61P, A61P37/06